This photo provided by Janssen Biotech, Inc. shows the drug Tremfya. On Thursday, July 13, 2017, the Food and Drug Administration approved the new drug Tremfya, from Johnson & Johnson, for people with moderate to severe plaque psoriasis. (Janssen Biotech, Inc. via AP)
Featured Photo Galleries
